FDA-Inspected Site

LEO Pharma Inc.

2 FDA inspections are on record for LEO Pharma Inc. in Parsippany, United States.

483· Form 483 issued

Parsippany, United States · Last updated July 10, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2014-09-19.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
15 Sep 2014 – 19 Sep 2014Human Drugs483View 483 →
9 May 2013 – 20 May 2013Human DrugsClean

Observations on record

Form 483 observations cited at this site, most recent first.

19 Sep 2014
21 CFR 314.80(b)

Failure to develop written procedures

Cited by Alberto A Viciedo

19 Sep 2014
21 CFR 314.80(c)(1)(i)

Late submission of 15-day report

Cited by Alberto A Viciedo

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 314.80(b)Cited across public-safe Form 483 observations1x
21 CFR 314.80(c)(1)(i)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind LEO Pharma Inc.'s 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat